CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 228 filers reported holding CONMED CORP in Q1 2019. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,455,258 | -45.3% | 53,996 | -26.4% | 0.01% | -40.0% |
| Q2 2023 | $9,964,728 | +9.4% | 73,329 | -16.4% | 0.02% | +7.1% |
| Q1 2023 | $9,107,457 | +16.0% | 87,690 | -1.0% | 0.01% | +7.7% |
| Q4 2022 | $7,848,232 | +35.2% | 88,541 | +23.5% | 0.01% | +30.0% |
| Q3 2022 | $5,806,000 | -17.4% | 71,699 | -0.4% | 0.01% | -9.1% |
| Q2 2022 | $7,030,000 | -17.8% | 72,002 | +25.1% | 0.01% | 0.0% |
| Q1 2022 | $8,551,000 | +0.5% | 57,563 | -3.1% | 0.01% | 0.0% |
| Q4 2021 | $8,506,000 | -5.9% | 59,377 | -14.1% | 0.01% | -15.4% |
| Q3 2021 | $9,041,000 | +58.0% | 69,110 | +66.0% | 0.01% | +62.5% |
| Q2 2021 | $5,723,000 | +25.9% | 41,641 | +19.6% | 0.01% | +14.3% |
| Q1 2021 | $4,546,000 | +18.1% | 34,810 | +1.3% | 0.01% | +16.7% |
| Q4 2020 | $3,850,000 | +25.3% | 34,376 | -12.0% | 0.01% | 0.0% |
| Q3 2020 | $3,073,000 | -35.7% | 39,067 | -41.2% | 0.01% | -33.3% |
| Q2 2020 | $4,781,000 | -50.2% | 66,417 | -60.4% | 0.01% | -57.1% |
| Q1 2020 | $9,610,000 | -54.7% | 167,813 | -11.6% | 0.02% | -32.3% |
| Q4 2019 | $21,227,000 | +20.6% | 189,817 | +3.7% | 0.03% | +10.7% |
| Q3 2019 | $17,598,000 | +51.6% | 183,030 | +34.9% | 0.03% | +55.6% |
| Q2 2019 | $11,608,000 | -11.9% | 135,662 | -14.3% | 0.02% | -18.2% |
| Q1 2019 | $13,169,000 | -7.0% | 158,314 | -28.2% | 0.02% | -12.0% |
| Q4 2018 | $14,156,000 | -18.0% | 220,492 | +1.2% | 0.02% | 0.0% |
| Q3 2018 | $17,261,000 | +8.0% | 217,884 | -0.2% | 0.02% | +4.2% |
| Q2 2018 | $15,988,000 | +86.2% | 218,426 | +61.1% | 0.02% | +84.6% |
| Q1 2018 | $8,588,000 | +60.6% | 135,606 | +29.3% | 0.01% | +85.7% |
| Q4 2017 | $5,346,000 | -13.9% | 104,885 | -11.4% | 0.01% | -22.2% |
| Q3 2017 | $6,211,000 | +70.7% | 118,365 | +65.8% | 0.01% | +80.0% |
| Q2 2017 | $3,638,000 | +90.0% | 71,409 | +65.6% | 0.01% | +66.7% |
| Q1 2017 | $1,915,000 | +0.3% | 43,129 | -0.3% | 0.00% | 0.0% |
| Q4 2016 | $1,910,000 | +6.6% | 43,249 | -3.3% | 0.00% | 0.0% |
| Q3 2016 | $1,792,000 | -40.6% | 44,727 | -29.2% | 0.00% | -40.0% |
| Q2 2016 | $3,016,000 | +15.9% | 63,197 | +1.8% | 0.01% | 0.0% |
| Q1 2016 | $2,603,000 | -1.8% | 62,057 | +3.1% | 0.01% | 0.0% |
| Q4 2015 | $2,652,000 | -6.5% | 60,207 | +1.3% | 0.01% | -16.7% |
| Q3 2015 | $2,836,000 | -22.9% | 59,407 | -5.9% | 0.01% | -14.3% |
| Q2 2015 | $3,677,000 | +17.1% | 63,107 | +1.4% | 0.01% | +40.0% |
| Q1 2015 | $3,141,000 | +14.5% | 62,207 | +2.0% | 0.01% | 0.0% |
| Q4 2014 | $2,743,000 | +22.8% | 61,007 | +0.7% | 0.01% | +25.0% |
| Q3 2014 | $2,233,000 | -21.3% | 60,607 | -5.7% | 0.00% | -20.0% |
| Q2 2014 | $2,839,000 | +4.4% | 64,293 | +2.7% | 0.01% | 0.0% |
| Q1 2014 | $2,720,000 | +1.6% | 62,607 | -0.6% | 0.01% | 0.0% |
| Q4 2013 | $2,678,000 | +26.0% | 63,007 | +0.8% | 0.01% | 0.0% |
| Q3 2013 | $2,125,000 | +9.8% | 62,507 | +0.9% | 0.01% | +25.0% |
| Q2 2013 | $1,936,000 | – | 61,957 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hood River Capital Management LLC | 448,126 | $38,346,000 | 1.80% |
| HealthCor Management, L.P. | 455,190 | $38,951,000 | 1.51% |
| Champlain Investment Partners, LLC | 1,452,360 | $124,278,000 | 1.04% |
| J. Goldman & Co LP | 162,771 | $13,928,000 | 0.96% |
| Granahan Investment Management | 189,925 | $16,252,000 | 0.80% |
| PURA VIDA INVESTMENTS, LLC | 50,000 | $4,279,000 | 0.65% |
| OAK RIDGE INVESTMENTS LLC | 102,797 | $8,797,000 | 0.61% |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 78,722 | $6,736,000 | 0.54% |
| MOODY ALDRICH PARTNERS LLC | 23,834 | $2,039,000 | 0.52% |
| 361 CAPITAL LLC | 30,901 | $2,644,000 | 0.47% |